Dr. Miguel Barreto is a recognized expert in artificial intelligence (AI), bioinformatics, and software development. Prior to APT, Dr. Barreto co-founded SimplicityBio (acquired by Precision Medicine Group in 2019) and Phages4A (a company active in the prediction of phage-bacteria interaction for the treatment of infections). Born in Colombia, South America, Dr. Barreto studied Electrical Engineering before moving to Switzerland in 2005 with a scholarship from the Swiss government to pursue his PhD at the University of Lausanne. His thought leadership has been rewarded with the 2015 “Venture Leaders Prize” and he was recognized by the Magazine L’Hebdo as one of the 100 people that will build the Switzerland of tomorrow.